|
 |
| |
 |
|
|
|
|
| |
management team
|
|
 |
Gordon Vehar, Ph.D. |
|
| |
Vice President, Research
Dr. Gordon Vehar is the former Vice President of
Research and Development for Raven Biotechnologies.
He is the inventor of numerous biotechnology patents
and the recipient of a collection of prestigious
scientific awards including two Distinguished Inventor
of the Year Awards from Intellectual Property Owners,
Inc.
Dr. Vehar also served in various roles throughout
a 20-year tenure with Genentech, including Director
of Cardiovascular Research and Staff Scientist
for Cardiovascular Research and Protein Chemistry.
Also at Genentech, he served as Project Team Leader
on various drug discovery and development projects,
which yielded four marketed products. He is the
recipient of the Murray Thelin Award for Outstanding
Research presented by the National Hemophilia
Foundation, the Inventor of the Year Award given
by Intellectual Property Owners, Inc., for the
human tissue plasminogen activator (t-PA) patent
for the treatment of heart attacks and stroke,
and the Distinguished Inventor of the Year Award
from Intellectual Property Owners, Inc. for the
patent on recombinant Factor VIII, a genetically
engineered clotting factor enabling production
of a therapeutic product for treating hemophilia
A. Dr. Vehar has served on the Scientific Advisory
Board for the Oklahoma Center for Molecular Medicine,
he is an inventor with 37 issued patents and is
the author of more than 35 publications. Dr. Vehar
received a Ph.D. from the University of Cincinnati
Medical School.
|
|
| |
|
|
|
|
|
